ClariTrial — AI Clinical Trial Intelligence

Explore/Cancer

Status

Phase

138,524 results for “Cancer”

Page 1 of 9235

NCT01296243

UNKNOWN

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Phase 2Prostate Cancer

Tesetaxel

Genta Incorporated57 participants4 sites · United StatesCompletes Aug 2012

CT.gov Full analysis →

NCT05228743

UNKNOWN

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

N/AGastric Cancer

Comparing Hyperthermic Intraperitoneal ChemotherapyPaclitaxelS1

Tianjin Medical University Cancer Institute and Hospital180 participants1 site · ChinaCompletes Aug 2023

CT.gov Full analysis →

NCT05829343

Recruiting

RObotic Versus LAparoscopic Colectomy for DIverticulitis.

N/ADiverticular DiseasesDiverticulitis

Laparoscopic Left colectomyRobotic left colectomy

S.M. Misericordia Hospital1,450 participants1 site · ItalyCompletes Mar 2025

CT.gov Full analysis →

NCT04814108

Recruiting

A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Phase 2Uterine Serous Carcinoma

ZN-c3

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc76 participants52 sites · United States, Australia, CanadaCompletes Nov 2024

CT.gov Full analysis →

NCT05622825

UNKNOWN

Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers

Phase 1Phase 2Advanced Liver Cancers

DC-CIK

National Taiwan University Hospital15 participantsCompletes Dec 2024

CT.gov Full analysis →

NCT01910025

Completed

PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy

Phase 2Non-Hodgkin's Lymphoma

ADI-PEG 20

Polaris Group18 participants5 sites · TaiwanCompletes Aug 2016

CT.gov Full analysis →

NCT05968417

Recruiting

Myeloma Novel Drug Discovery Ver 1.2

N/AMultiple Myeloma

Observational study - sample collection only.

Institute of Cancer Research, United Kingdom250 participants1 site · United KingdomCompletes Feb 2033

CT.gov Full analysis →

NCT05294640

Completed

Results posted

Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Phase 4Eyelid TumorEyelid BumpEyelid Deformity

0.9% Bacteriostatic Local Anesthetic Injection1% Lidocaine with 1:100,000 epinephrine Local Anesthetic InjectionEyelid Lesion Removal

University of California, San Francisco95 participants1 site · United StatesCompletes Feb 2023

CT.gov Full analysis →

NCT04791540

Recruiting

Sarcopenia and Nutritional Status in a Rehabilitation Setting

N/ASarcopenia

handgrip strenghtBioelectrical Impedance Analysis (BIA)MUST+4 more

Fondazione Don Carlo Gnocchi Onlus30 participants1 site · ItalyCompletes Dec 2025

CT.gov Full analysis →

NCT04151940

Recruiting

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

N/AMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Positron Emission TomographyComputed TomographyChemotherapy+4 more

University of Washington80 participants1 site · United StatesCompletes Nov 2027

CT.gov Full analysis →

NCT05116189

Active

Results posted

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

Phase 3Ovarian CancerCarcinoma, Ovarian EpithelialFallopian Tube Neoplasms

PembrolizumabPaclitaxelBevacizumab+2 more

Merck Sharp & Dohme LLC643 participants187 sites · United States, Australia, BelgiumCompletes Mar 2025

CT.gov Full analysis →

NCT04403568

Withdrawn

Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate

Early Phase 1Prostate Cancer

Ursolic AcidCurcumin

The University of Texas Health Science Center at San Antonio01 site · United StatesCompletes Dec 2022

CT.gov Full analysis →

NCT07067268

Recruiting

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Phase 2Nasopharyngeal Cancinoma (NPC)

Adjuvant therapy

Fudan University76 participants1 site · ChinaCompletes Sep 2026

CT.gov Full analysis →

NCT03163368

Active

Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors

Early Phase 1Brain Metastases

Neoadjuvant stereotactic radiosurgeryNeurosurgical resection

Cedars-Sinai Medical Center25 participants1 site · United StatesCompletes Dec 2022

CT.gov Full analysis →

NCT05504291

Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Phase 2Bilateral RetinoblastomaChildhood Intraocular RetinoblastomaGroup D Retinoblastoma

Biospecimen CollectionCarboplatinEtoposide+5 more

Children's Oncology Group26 participants20 sites · United States, Australia, CanadaCompletes Mar 2028

CT.gov Full analysis →

1–15 of 138,524

Explore/Cancer

Status

Phase

138,524 results for “Cancer”

Page 1 of 9235

NCT01296243

UNKNOWN

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Phase 2Prostate Cancer

Tesetaxel

Genta Incorporated57 participants4 sites · United StatesCompletes Aug 2012

CT.gov Full analysis →

NCT05228743

UNKNOWN

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

N/AGastric Cancer

Comparing Hyperthermic Intraperitoneal ChemotherapyPaclitaxelS1

Tianjin Medical University Cancer Institute and Hospital180 participants1 site · ChinaCompletes Aug 2023

CT.gov Full analysis →

NCT05829343

Recruiting

RObotic Versus LAparoscopic Colectomy for DIverticulitis.

N/ADiverticular DiseasesDiverticulitis

Laparoscopic Left colectomyRobotic left colectomy

S.M. Misericordia Hospital1,450 participants1 site · ItalyCompletes Mar 2025

CT.gov Full analysis →

NCT04814108

Recruiting

A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Phase 2Uterine Serous Carcinoma

ZN-c3

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc76 participants52 sites · United States, Australia, CanadaCompletes Nov 2024

CT.gov Full analysis →

NCT05622825

UNKNOWN

Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers

Phase 1Phase 2Advanced Liver Cancers

DC-CIK

National Taiwan University Hospital15 participantsCompletes Dec 2024

CT.gov Full analysis →

NCT01910025

Completed

PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy

Phase 2Non-Hodgkin's Lymphoma

ADI-PEG 20

Polaris Group18 participants5 sites · TaiwanCompletes Aug 2016

CT.gov Full analysis →

NCT05968417

Recruiting

Myeloma Novel Drug Discovery Ver 1.2

N/AMultiple Myeloma

Observational study - sample collection only.

Institute of Cancer Research, United Kingdom250 participants1 site · United KingdomCompletes Feb 2033

CT.gov Full analysis →

NCT05294640

Completed

Results posted

Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Phase 4Eyelid TumorEyelid BumpEyelid Deformity

0.9% Bacteriostatic Local Anesthetic Injection1% Lidocaine with 1:100,000 epinephrine Local Anesthetic InjectionEyelid Lesion Removal

University of California, San Francisco95 participants1 site · United StatesCompletes Feb 2023

CT.gov Full analysis →

NCT04791540

Recruiting

Sarcopenia and Nutritional Status in a Rehabilitation Setting

N/ASarcopenia

handgrip strenghtBioelectrical Impedance Analysis (BIA)MUST+4 more

Fondazione Don Carlo Gnocchi Onlus30 participants1 site · ItalyCompletes Dec 2025

CT.gov Full analysis →

NCT04151940

Recruiting

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

N/AMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Positron Emission TomographyComputed TomographyChemotherapy+4 more

University of Washington80 participants1 site · United StatesCompletes Nov 2027

CT.gov Full analysis →

NCT05116189

Active

Results posted

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

Phase 3Ovarian CancerCarcinoma, Ovarian EpithelialFallopian Tube Neoplasms

PembrolizumabPaclitaxelBevacizumab+2 more

Merck Sharp & Dohme LLC643 participants187 sites · United States, Australia, BelgiumCompletes Mar 2025

CT.gov Full analysis →

NCT04403568

Withdrawn

Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate

Early Phase 1Prostate Cancer

Ursolic AcidCurcumin

The University of Texas Health Science Center at San Antonio01 site · United StatesCompletes Dec 2022

CT.gov Full analysis →

NCT07067268

Recruiting

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Phase 2Nasopharyngeal Cancinoma (NPC)

Adjuvant therapy

Fudan University76 participants1 site · ChinaCompletes Sep 2026

CT.gov Full analysis →

NCT03163368

Active

Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors

Early Phase 1Brain Metastases

Neoadjuvant stereotactic radiosurgeryNeurosurgical resection

Cedars-Sinai Medical Center25 participants1 site · United StatesCompletes Dec 2022

CT.gov Full analysis →

NCT05504291

Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Phase 2Bilateral RetinoblastomaChildhood Intraocular RetinoblastomaGroup D Retinoblastoma

Biospecimen CollectionCarboplatinEtoposide+5 more

Children's Oncology Group26 participants20 sites · United States, Australia, CanadaCompletes Mar 2028

CT.gov Full analysis →

1–15 of 138,524